Skip to main content

Long-term effectiveness of risperidone and olanzapine in resistant or intolerant schizophrenic patients. A mirror study

Buy Article:

$51.00 plus tax (Refund Policy)

Abstract:

Søholm B, Lublin H. Long-term effectiveness of risperidone and olanzapine in resistant or intolerant schizophrenic patients. A mirror study.

Acta Psychiatr Scand 2003: 107: 344–350. © Blackwell Munksgaard 2003. Objective: 

To evaluate the long-term effectiveness of the second generation antipsychotics, risperidone and olanzapine on hospitalization, clinical response, and adherence to therapy after switching from conventional antipsychotics or clozapine in a naturalistic setting of schizophrenic patients. Method: 

Data were registered for periods of identical duration before and after switching. Results: 

Fifty-seven patients were included. Mean study period was 3.1 ± 0.2 years. Mean number of in-patient days after switching declined by 78% of the level before switching (P=0.0002). There was no significant differences in ratio responders/non-responders between the subgroups. The number of patients with extrapyramidal symptoms (EPS) was significantly reduced after switching. However, intolerable weight gain led to a lack of adherence to therapy in 18% of the olanzapine-treated patients. Conclusion: 

Long-term treatment with the second generation antipsychotics, risperidone and olanzapine significantly improved the clinical outcome. However, weight gain may be a significant reason for discontinuation of treatment and reducing the long-term adherence to therapy.

Keywords: compliance; olanzapine; risperidone; schizophrenia; weight gain

Document Type: Research Article

DOI: http://dx.doi.org/10.1034/j.1600-0447.2003.00063.x

Affiliations: Psychiatric Department O, Psychiatric Clinic, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

Publication date: May 1, 2003

mksg/acp/2003/00000107/00000005/art00005
dcterms_title,dcterms_description,pub_keyword
6
5
20
40
5

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more